ORBIMED ADVISORS LLC

CIK 000105595111 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001055951

Recent Transactions

50 trades

Purchase
Anthera Pharmaceuticals Inc
Common Stock
2010-09-30$4.08/sh+19,900→ 3,449,734 total
Purchase
Anthera Pharmaceuticals Inc
Common Stock
2010-09-30$4.08/sh+19,900→ 3,449,734 total
Purchase
NxStage Medical, Inc.
Common Stock
2008-08-26$3.50/sh+27,700→ 5,718,256 total
Purchase
NxStage Medical, Inc.
Common Stock
2008-08-26$3.50/sh+27,700→ 5,718,256 total
Award
NxStage Medical, Inc.
Director's Stock Option (right to buy)
2008-07-23+11,667→ 11,667 total
Award
NxStage Medical, Inc.
Director's Stock Option (right to buy)
2008-07-23+11,667→ 11,667 total
Purchase
NxStage Medical, Inc.
Warrant (right to buy)
2008-05-23+1,111,111→ 1,111,111 total
Purchase
NxStage Medical, Inc.
Warrant (right to buy)
2008-05-23+1,111,111→ 1,111,111 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Other
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Other
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Other
AVANIR PHARMACEUTICALS, INC.
Common Stock
2006-05-31$9.79/sh−629,121→ 1,706,137 total
Conversion
CRYOCOR INC
Series D Redeemable Convertible Preferred Stock
2005-07-13−30,241,936
Conversion
CRYOCOR INC
Common Stock
2005-07-13+1,096,936→ 1,231,936 total
Conversion
CRYOCOR INC
Common Stock
2005-07-13+1,096,936→ 1,231,936 total
Conversion
CRYOCOR INC
Series D Redeemable Convertible Preferred Stock
2005-07-13−30,241,936
Conversion
CRYOCOR INC
Common Stock
2005-07-13+1,096,936→ 1,231,936 total
Conversion
CRYOCOR INC
Series D Redeemable Convertible Preferred Stock
2005-07-13−30,241,936
Conversion
CRYOCOR INC
Common Stock
2005-07-13+1,096,936→ 1,231,936 total
Conversion
CRYOCOR INC
Series D Redeemable Convertible Preferred Stock
2005-07-13−30,241,936
Other
GIVEN IMAGING LTD
Common Stock
2004-09-21$39.32/sh−235,005→ 3,637,255 total
Other
GIVEN IMAGING LTD
Common Stock
2004-09-21$39.32/sh−235,005→ 3,637,255 total
Other
GIVEN IMAGING LTD
Common Stock
2004-09-21$39.32/sh−235,005→ 3,637,255 total
Other
GIVEN IMAGING LTD
Common Stock
2004-09-21$39.32/sh−235,005→ 3,637,255 total
Sale
GIVEN IMAGING LTD
Common Stock
2004-06-23$30.08/sh−170,000→ 3,872,260 total
Sale
GIVEN IMAGING LTD
Common Stock
2004-06-23$30.08/sh−170,000→ 3,872,260 total
Sale
GIVEN IMAGING LTD
Common Stock
2004-06-23$30.08/sh−170,000→ 3,872,260 total
Sale
GIVEN IMAGING LTD
Common Stock
2004-06-23$30.08/sh−170,000→ 3,872,260 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Preferred Stock
2004-04-08−883,722→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+1,006,280→ 1,006,280 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Preferred Stock
2004-04-08−2,000,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Preferred Stock
2004-04-08−883,722→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Preferred Stock
2004-04-08−883,722→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+1,006,280→ 1,006,280 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Preferred Stock
2004-04-08−2,000,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+1,006,280→ 1,006,280 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Preferred Stock
2004-04-08−2,000,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Preferred Stock
2004-04-08−883,722→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Preferred Stock
2004-04-08−2,000,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+1,006,280→ 1,006,280 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Preferred Stock
2004-04-08−883,722→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Preferred Stock
2004-04-08−2,000,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Preferred Stock
2004-04-08−2,000,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+1,006,280→ 1,006,280 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Preferred Stock
2004-04-08−883,722→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Preferred Stock
2004-04-08−883,722→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+1,006,280→ 1,006,280 total

Companies

Recent Filings

Address

767 3RD AVENUE 30TH FLOOR

NEW YORK, NY, 10017

View on SEC.gov